ArticleTherapeutic advances in medical oncology2022

Improved overall survival of metastatic renal cell carcinoma patients in the era of modern tyrosine kinase inhibitors and immune checkpoint inhibitors: results from a real-life, population-based Austrian study comprising three decades of follow-up.

Hannah Fluhrer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.